A Phase 2a Multi-Center, Prospective, Randomized Controlled Study to Evaluate the Safety and Efficacy of Topically Applied PEP-TISSEEL in Subjects With Diabetic Foot Ulcers (DFU)
Conditions: Diabetic Foot Ulcer Interventions: Biological: PEP (Purified Exosome Product) / TISSEEL Sponsors: Rion Inc.; Professional Education and Research Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetic Ulcers | Education | Endocrinology | Research | Study | Universities & Medical Training